Kinetics of irreversible protein aggregation: Analysis of extended Lumry-Eyring models and implications for predicting protein shelf life

Journal of Physical Chemistry B

Volumn 107, Issue 5, 2003, Pages 1194-1207

  Roberts, Christopher J ^a  

^a University of Delaware   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

INTRINSIC AGGREGATION KINETICS; IRREVERSIBLE PROTEIN AGGREGATION; LUMRY-EYRING MODELS; NON-NATIVE CONFORMATIONS; REVERSIBLE CONFORMATIONAL TRANSITIONS;

AGGLOMERATION; COMPUTER SIMULATION; CONFORMATIONS; HYDROPHOBICITY; MONOMERS; REACTION KINETICS; SOLUTIONS; TEMPERATURE;

PROTEINS;

EID: 0037421836     PISSN: 10895647     EISSN: None     Source Type: Journal    
DOI: 10.1021/jp026827s     Document Type: Article

References (69)

1. Bummer, P. M.; Koppenol, S. Drugs Pharm. Sci. 2000, 99, 5-69.
2. Cleland, J. L.; Powell, M. F.; Shire, S. J. Crit. Rev. Ther. Drug Carrier Syst. 1993, 10, 307-377.
3. Middaugh, C. R.; Edwards, K.-L. T. Exp. Opin. Invest. Drugs 1998, 7, 1493-1500.
4. Pikal, M. J. In Freeze-Drying/Lyophilization of Pharmaceutical and Biological Products; Rey, L., May, J. C., Eds.; Marcel Dekker: New York, 1999; pp 161-198.
5. Remmele, R. L., Jr., Bhat, S. D.; Phan, D. H.; Gombotz, W. R. Biochemistry 1999, 38, 5241-5247.
6. Grillo, A. O.; Edwards, K.-L. T.; Kashi, R. S.; Shipley, K. M.; Hu, L.; Besman, M. J.; Middaugh, C. R. Biochemistry 2001, 40, 586.
7. Kendrick, B. S.; Carpenter, J. F.; Cleland, J. L.; Randolph, T. W. Proc. Natl. Acad. Sci. U.S.A. 1998, 95, 14142.
8. Finke, J. M.; Roy, M.; Zimm, B. H.; Jennings, P. A. Biochemistry 2000, 39, 575-583.
9. Fink, A. L. Folding Des. 1998, 3, R9-R23.
10. Baier, S.; McClements, D. J. J. Agric. Food Chem. 2001, 49, 2600-2608.
11. Verheul, M.; Roefs, S. P. F. M.; de Kruif, K. G. J. Agric. Food Chem. 1998, 46, 896-903.
12. Foguel, D.; Robinson, C. R.; de Sousa, P. C., Jr.; Silva, J. L.; Robinson, A. S. Biotechnol. Bioeng. 1999, 63, 552-558.
13. Shi, P.-Y.; Maizels, N.; Weiner, A. M. BioTechniques 1997, 23, 1036-1038.
14. Jaenicke, R. Philos. Trans. R. Soc. London, Ser. B 1995, 348, 97-105.
15. Kim, Y.-S.; Wall, J. S.; Meyer, J.; Murphy, C.; Randolph, T. W.; Manning, M. C.; Solomon, A.; Carpenter, J. F. J. Biol. Chem. 2000, 275, 1570-1574.
16. Wood, S. J.; Wypych, J.; Steavenson, S.; Louis, J.-C.; Citron, M.; Biere, A. L. J. Biol. Chem. 1999, 274, 19509-19512.
17. Esler, W. P.; Stimson, E. R.; Ghilardi, J. R.; Vinters, H. V.; Lee, J. P.; Mantyh, P. W.; Maggio, J. E. Biochemistry 1996, 35, 749-757.
18. Nielsen, L.; Khurana, R.; Coats, A.; Frokjaer, S.; Brange, J.; Vyas. S.; Uversky, V.; Fink, A. L. Biochemistry 2001, 40, 6036-6046.
19. Mulkerrin, M. G.; Wetzel, R. Biochemistry 1989, 28, 6556-6561.
20. Lomakin, A.; Teplow, D. B.; Kirschner, D. A.; Benedek, G. B. Proc. Natl. Acad. Sci. U.S.A. 1997, 94, 7942-7947.
21. Yoshioka, S.; Aso, Y.; Isutsu, K.-I.; Kojima, S. Pharm. Res. 1994, 11, 1721-1725.
22. Plaza del Pino, I. M.; Ibarra-Molero, B.; Sanchez-Ruiz, J. M. Proteins: Struct., Funct., Genet. 2000, 40, 58.
23. Dill, K. A. Biochemistry 1990, 29, 7133-7155.
24. Zaks, A. In Stability of Protein Pharmaceuticals; Ahern, T. J., Manning, M. C., Eds.; Plenum Press: New York, 1992; pp 249-272.
25. Fink, A. L.; Calciano, L. J.; Goto, Y.; Kurotsu, T.; Palleros, D. R. Biochemistry 1994, 33, 12504-12511.
26. Petsev, D. N.; Thomas, B. R.; Yau, S.-T.; Vekilov, P. G. Biophys. J. 2000, 78, 2060-2069.
27. Kheterpal, I.; Williams, A.; Murphy, C.; Bledsoe, B.; Wetzel, R. Biochemistry 2001, 40, 11757-11767.
28. Hammarstrom, P.; Persson, M.; Freskgard, P.-O.; Martensson, L.-G.; Andersson, D.; Jonsson, B.-H.; Carlsson, U. J. Biol. Chem. 1999, 274, 32897-32903.
29. Smellar, L.; Rubens, P.; Heremans, K. Biochemistry 1999, 38, 3816-3820.
30. Narhi, L.; Wood; S. J.; Steavenson; S.; Jiang, Y.; Wu, G. M.; Anafi, D.; Kaufman, S. A.; Martin, F.; Sitney, K.; Denis, P.; Louis, J.-C.; Wypych, J.; Biere, A. L.; Citron, M. J. Biol. Chem. 1999, 14, 9843-9846.
31. Naiki, H.; Hasegawa, K.; Yamaguchi, I.; Nakamura, H.; Gejyo, F.; Nakakuki, K. Biochemistry 1998, 37, 17882-17889.
32. We use the term conformational state within its thermodynamic and statistical thermodynamic sense to indicate all conformations of a protein and its environment (i.e., solvent and additional solutes) within a given ensemble, or rational subdivision of an ensemble, consistent with a set of macroscopic observables specific to that state.
33. Onuchic, J. N.; Luthey-Schulten, Z.; Wolynes, P. G. Annu. Rev. Phys. Chem. 1997, 48, 545-600.
34. Abkevich, V. I.; Gutin, A. M.; Shakhnovich, E. I. J. Chem. Phys. 1994, 101, 6052-6062.
35. Krishnan, S.; Chi, E. Y.; Webb, J. N.; Chang, B. S.; Shan, D.; Goldenberg, M.; Manning, M. C.; Randolph, T. W.; Carpenter, J. F. Biochemistry, 2002, 41, 6422.
36. Lindner, R. A.; Treweek, T. M.; Carver, J. A. Biochem. J. 2001, 354, 79-87.
37. Oliveberg, M. Acc. Chem. Res. 1998, 31, 765.
38. Khurana, R.; Gillespie, J. R.; Talapatra, A.; Minert, L. J.; Jonescu-Zanetti, C.; Millett, I.; Fink, A. L. Biochemistry 2001, 40, 3525-3535.
39. 38,40,41
40. Kauzmann, W. In Advances in Protein Chemistry; Anfinsen, C. B., Anson, M. L., Bailey, K., Edsall, J. T., Eds.; Academic Press: New York, 1959; Vol. 14, pp 1-63.
41. Pappu, R. V.; Rose, G. D. Protein Sci. 2002, 11, 2437-2455.
42. Rucker, A. L.; Creamer, T. R. Protein Sci. 2002, 11, 980-985.
43. For the purposes of the extended Lumry-Eyring model employed here as well for extrapolating shelf-life predictions, it is not necessary to know detailed identity (e.g., in terms of structural details) of the aggregation-prone state(s). The major requirement is that it(they) remain the predominant aggregation-prone state(s) over the range of the variable being extrapolated.
44. Lumry, R.; Eyring, H. J. Phys. Chem. 1954, 58, 110-120.
45. Zale S. E.; Klibanov A. M. Biotech. Bioeng. 1983, 25, 2221-2230.
46. Sanchez-Ruiz, J. M. Biophys. J. 1992, 61, 921-935.
47. Tello-Solis, S.; Hernandez-Arana, A. Biochem. J. 1995, 31, 969.
48. La Rosa, C.; Milardi, D.; Grasso, D.; Guzzi, R.; Sportelli, L. J. Phys. Chem. 1995, 99, 14864-14870.
49. Kasraian, K.; Kuzniar, A.; Earley, D.; Kamicker, B.; Wilson, G.; Manion, T.; Hong, J.; Reiber, C.; Canning, P. Pharm. Dev. Technol. 2001, 6, 439-445.
50. Webb, J.N.; Webb, S. D.; Cleland, J. L.; Carpenter, J. F.; Randolph, T. W. Proc. Natl. Acad. Sci U.S.A. 2001, 98, 7259.
51. Roberts, C. J.; Darrington, R. T.; Whitley, M. B. J. Pharm. Sci., in press.
52. 0).
53. Fields, G. B.; Alonso, D. O. V.; Stigter, D.; Dill, K. A. J. Phys. Chem. 1992, 96, 3974.
54. Bartkowski, R. E.; Kitchel, R.; Peckham, N. R.; Margulis, J. J. Protein Chem. 2002, 21, 137.
55. Becktel, W. J.; Schellman, J. A. Biopolymers 1987, 26, 1859-1877.
56. Pace, C. N.; Shirley, B. A.; Thomson, J. A. In Protein Structure; Creighton, T. E., Ed.; Oxford University Press: Oxford, U.K., 1990; p. 311.
57. Laidler, K. J. Chemical Kinetics, 3rd ed.; HarperCollins: New York, 1987.
58. Mikol, V.; Giege, R. In Crystallization of Nucleic Acids and Proteins; Ducruix, A., Giege, R., Eds.; Oxford University Press: New York, 1992; pp 219-240.
59. 3 days.
60. Teplow, D. B. Amyloid 1998, 5, 121-142.
61. Barzykin, A. V.; Shushin, A. I. Biophys. J. 2001, 80, 2062-2073.
62. Privalov, P. L. Adv. Protein Chem. 1979, 33, 167-241.
63. Solc, K.; Stockmayer, W. H. Int. J. Chem. Kinet. 1973, 5, 733-752.
64. Remmele, R. A. Arrhenius Consequences of IL-1R(II) Aggregation in the Vicinity of the Tm. Formulation Strategies for Biopharmaceuticals, IBC USA, Miami, FL, 2002.
65. Segawa, S.-I.; Sugihara, M. Biopolymers 1984, 23, 2473-2788.
66. Oliveberg, M.; Tan, Y.-J.; Fersht, A. R. Proc. Natl. Acad. Sci. U.S.A. 1995, 92, 8926-8929.
67. Yoshioka, S.; Izutsu, K.; Aso, Y.; Takeda, Y. Pharm. Res. 1991, 8, 480-484.
68. Goers, J.; Permyakov, S. E.; Permyakov, E. A.; Uversky, V. N.; Fink, A. L. Biochemistry 2002, 41, 12546-12551.
69. Karplus, M. J. Phys. Chem. B 2000, 104, 11-27.